NEW YORK & MIAMI, April 01, 2024–(BUSINESS WIRE)–Aterian Investment Partners (“Aterian”), a private investment firm, is pleased to announce that one of its affiliates has entered into an agreement to recapitalize Contract Pharmaceuticals Limited Canada (“CPL” or the “Company”), a leading North American contract development and manufacturing organization (CDMO) of non-sterile liquid and semi-solid dosage forms.
CPL, based in Mississauga, Ontario, Canada, is an industry leader with longstanding relationships with 15 of the top 20 global pharmaceutical companies. The Company supports its customers through its FDA and Health Canada-registered facilities, selling into North America, the European Union, Japan, Australia, Mexico, Brazil, and the Middle East.
Christopher H. Thomas, Co-Founder & Partner at Aterian, stated, “CPL is a North American market leader in developing…
